Neurocrine Biosciences Stock Price History

NBIX Stock  USD 143.26  1.34  0.94%   
Below is the normalized historical share price chart for Neurocrine Biosciences extending back to May 23, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Neurocrine Biosciences stands at 143.26, as last reported on the 18th of January 2025, with the highest price reaching 144.82 and the lowest price hitting 141.57 during the day.
IPO Date
23rd of May 1996
200 Day MA
132.9247
50 Day MA
130.5534
Beta
0.353
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Neurocrine Stock, it is important to understand the factors that can impact its price. Neurocrine Biosciences appears to be very steady, given 3 months investment horizon. Neurocrine Biosciences has Sharpe Ratio of 0.2, which conveys that the firm had a 0.2% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Neurocrine Biosciences, which you can use to evaluate the volatility of the firm. Please exercise Neurocrine Biosciences' Downside Deviation of 1.5, mean deviation of 1.2, and Risk Adjusted Performance of 0.1652 to check out if our risk estimates are consistent with your expectations.
  
At this time, Neurocrine Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 3.9 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 61.8 M in 2025. . At this time, Neurocrine Biosciences' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 6.13 in 2025, whereas Price To Sales Ratio is likely to drop 5.83 in 2025. Neurocrine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.198

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNBIX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.76
  actual daily
15
85% of assets are more volatile

Expected Return

 0.35
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.2
  actual daily
15
85% of assets perform better
Based on monthly moving average Neurocrine Biosciences is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurocrine Biosciences by adding it to a well-diversified portfolio.
Price Book
5.2848
Enterprise Value Ebitda
24.0913
Price Sales
6.4672
Shares Float
100.1 M
Wall Street Target Price
167.6713

Neurocrine Biosciences Stock Price History Chart

There are several ways to analyze Neurocrine Stock price data. The simplest method is using a basic Neurocrine candlestick price chart, which shows Neurocrine Biosciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 17, 2025143.26
Lowest PriceOctober 23, 2024115.08

Neurocrine Biosciences January 18, 2025 Stock Price Synopsis

Various analyses of Neurocrine Biosciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurocrine Stock. It can be used to describe the percentage change in the price of Neurocrine Biosciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurocrine Stock.
Neurocrine Biosciences Price Daily Balance Of Power 0.41 
Neurocrine Biosciences Price Action Indicator 0.73 
Neurocrine Biosciences Price Rate Of Daily Change 1.01 

Neurocrine Biosciences January 18, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Neurocrine Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Neurocrine Biosciences intraday prices and daily technical indicators to check the level of noise trading in Neurocrine Stock and then apply it to test your longer-term investment strategies against Neurocrine.

Neurocrine Stock Price History Data

The price series of Neurocrine Biosciences for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 28.18 with a coefficient of variation of 6.6. The daily prices for the period are spread out with arithmetic mean of 127.86. The median price for the last 90 days is 126.75. The company issued dividends to stockholders on 1995-12-29.
OpenHighLowCloseVolume
01/18/2025
 142.85  144.82  141.57  143.26 
01/17/2025 142.85  144.82  141.57  143.26  976,444 
01/16/2025 142.75  143.50  140.73  141.92  776,124 
01/15/2025 140.48  142.64  138.66  142.56  829,151 
01/14/2025 142.46  144.24  139.39  139.51  985,246 
01/13/2025 141.00  144.00  138.46  143.03  1,226,643 
01/10/2025 137.75  142.83  137.49  140.90  1,117,740 
01/08/2025 137.62  139.20  137.00  138.71  899,058 
01/07/2025 137.73  139.43  136.84  137.55  962,407 
01/06/2025 138.30  139.72  136.13  136.85  1,109,003 
01/03/2025 138.32  139.52  137.17  138.10  745,445 
01/02/2025 137.07  139.47  136.72  137.86  853,138 
12/31/2024 138.10  138.85  136.01  136.50  689,564 
12/30/2024 138.07  138.65  136.96  137.06  747,632 
12/27/2024 139.09  139.82  138.34  139.44  602,647 
12/26/2024 135.98  139.10  135.94  139.03  920,952 
12/24/2024 137.51  138.12  135.84  136.53  341,447 
12/23/2024 135.37  137.11  132.83  136.99  1,302,665 
12/20/2024 134.98  137.01  134.12  135.42  2,265,598 
12/19/2024 135.52  136.37  133.26  134.96  983,185 
12/18/2024 137.00  140.00  134.26  135.45  2,132,994 
12/17/2024 132.51  137.24  132.10  136.69  1,578,232 
12/16/2024 127.67  134.81  127.35  133.05  1,651,133 
12/13/2024 126.70  127.05  125.61  126.70  777,757 
12/12/2024 128.22  128.63  126.63  126.79  553,516 
12/11/2024 129.00  129.68  127.29  128.22  725,302 
12/10/2024 129.67  130.48  127.58  128.96  804,931 
12/09/2024 128.33  129.42  128.02  129.12  682,500 
12/06/2024 126.96  128.93  126.96  128.14  547,973 
12/05/2024 126.82  128.00  125.74  126.42  540,445 
12/04/2024 125.47  127.90  125.21  127.74  660,716 
12/03/2024 125.41  126.98  125.26  125.44  751,295 
12/02/2024 126.16  128.00  125.77  125.89  819,742 
11/29/2024 126.15  127.08  125.50  126.75  403,268 
11/27/2024 127.91  128.27  125.43  126.59  739,665 
11/26/2024 127.15  128.14  124.23  127.91  757,856 
11/25/2024 125.94  127.81  125.02  127.11  1,563,590 
11/22/2024 125.18  127.00  124.38  125.65  1,206,787 
11/21/2024 123.27  126.13  122.37  125.00  1,201,799 
11/20/2024 119.36  124.01  118.91  123.29  1,435,150 
11/19/2024 116.34  119.79  115.27  119.13  1,092,819 
11/18/2024 117.46  118.32  116.33  117.62  1,045,412 
11/15/2024 122.10  122.69  117.36  117.44  1,255,337 
11/14/2024 125.53  125.89  122.58  122.88  876,531 
11/13/2024 127.19  127.84  125.51  125.51  807,393 
11/12/2024 126.95  128.24  126.39  127.01  893,295 
11/11/2024 125.77  129.67  125.75  127.17  1,267,684 
11/08/2024 124.91  126.28  123.76  125.74  561,756 
11/07/2024 125.29  126.65  123.50  123.98  755,190 
11/06/2024 124.10  126.48  122.47  125.30  1,214,670 
11/05/2024 120.01  122.00  119.08  121.53  748,197 
11/04/2024 121.27  122.32  119.70  120.53  1,018,488 
11/01/2024 120.52  123.00  120.52  122.21  1,512,407 
10/31/2024 122.52  123.04  119.42  120.27  1,362,570 
10/30/2024 126.46  131.26  124.15  124.33  2,596,274 
10/29/2024 115.79  116.86  115.08  116.19  1,136,607 
10/28/2024 115.81  117.95  115.81  116.20  676,278 
10/25/2024 115.69  117.41  113.88  116.08  1,009,703 
10/24/2024 115.55  117.57  114.45  115.52  797,395 
10/23/2024 116.37  116.69  114.55  115.08  581,975 
10/22/2024 115.68  117.20  115.68  116.78  576,884 

About Neurocrine Biosciences Stock history

Neurocrine Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurocrine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurocrine Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurocrine Biosciences stock prices may prove useful in developing a viable investing in Neurocrine Biosciences
Last ReportedProjected for Next Year
Common Stock Shares Outstanding116.2 M61.8 M
Net Income Applicable To Common Shares177.7 M186.6 M

Neurocrine Biosciences Quarterly Net Working Capital

1.45 Billion

Neurocrine Biosciences Stock Technical Analysis

Neurocrine Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurocrine Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurocrine Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Neurocrine Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neurocrine Biosciences' price direction in advance. Along with the technical and fundamental analysis of Neurocrine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurocrine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Neurocrine Stock Analysis

When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.